Accelerating Cancer Drug Development

Accelerating Cancer Drug Development -From target to patients, BioNow will be hosting this event at Alderley Park on the 27th of February 2018. Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst [...]

By |2018-07-11T11:58:57+00:00February 27th, 2018|Events|Comments Off on Accelerating Cancer Drug Development

ApconiX named start up of the year!

We were delighted to be named 2017 Start Up Start-Up of the Year by BioNow, the northern England bio-medical and life sciences membership organisation. It's been an outstanding year for ApconiX with more than 60 clients across the UK, US and Europe including Pfizer, UCB and Gilead, as well as bio-techs, start-ups and university spin-outs. [...]

By |2018-06-06T14:48:46+00:00December 11th, 2017|Events|Comments Off on ApconiX named start up of the year!

ApconiX Achieves Five-Fold Turnover Boost

The business has just received the accolade of Start-Up of the Year at the 17th awards hosted by BioNow, the northern England bio-medical and life sciences membership organisation. The company’s early success is based on delivering expertise in safety toxicology and ion channel electrophysiology to a changing pharmaceutical sector, in which more companies are outsourcing [...]

By |2018-07-11T14:31:30+00:00December 7th, 2017|Press|Comments Off on ApconiX Achieves Five-Fold Turnover Boost